Study to Evaluate the Safety, Tolerability, PK, and PD of BMS-986090 in Healthy Subjects

Double-Blinded, Randomized, Placebo-Controlled, Single Ascending Dose and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986090 in Healthy Subjects

The purpose of this study is to evaluate the safety and tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of BMS-986090 in healthy subjects.

For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com.

Inclusion Criteria:

• Healthy male and female (of not childbearing potential), ages 18-45 years, inclusive
• BMI 18 to 32 kg/m2, inclusive

Exclusion Criteria:

- Any significant acute or chronic medical illness